The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ ...

Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP: San Diego Monday, April 14, 2025, ...

This column provides an overview of restraint in psittacine birds and administration of subcutaneous fluids and intramuscular injections ... the bird's daily fluid volume (calculated at 50 ...

Based on these data, we believe that further development of subcutaneous sabirnetug ... that enables large volume SC injection with increased dispersion and absorption of co-administered therapies.

It will review intramuscular and subcutaneous injection techniques in pediatric patients, including site selection, needle length, the maximum volume to be administered, and administration process. It ...

Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) today announces positive interim results from its randomized, double-blind, placebo-controlled Phase Ib single subcutaneous (SQ) injection study ( ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Weekly subcutaneous administration of sabirnetug ... that enables large volume SC injection with increased dispersion and absorption of co-administered therapies. ENHANZE® has been commercially ...